|
Jan 9
|
2024 Marks a New Era Of Pharmaceutical Innovation
|
|
Jan 9
|
Ambrx (AMAM) Skyrockets 102% on $2B Buyout Offer From J&J
|
|
Jan 9
|
JPM24: Pfizer’s tough sell, the next Karuna and building a biotech platform
|
|
Jan 9
|
MercadoLibre and Pfizer have been highlighted as Zacks Bull and Bear of the Day
|
|
Jan 9
|
UPDATE 2-BioNTech predicts return to revenue growth in 2025
|
|
Jan 2
|
Moderna Stock Starts 2024 With an Upgrade After a Terrible Year. Here’s Why.
|
|
Jan 2
|
10 clinical trials to watch in the first half of 2024
|
|
Dec 30
|
Got $5,000? Buy and Hold These 3 Value Stocks for Years
|
|
Dec 29
|
2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer
|
|
Dec 29
|
Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January
|
|
Dec 28
|
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.
|
|
Dec 28
|
S&P 500 Is Nearing a Record High. This Could Derail It in 2024.
|
|
Dec 28
|
Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge?
|
|
Dec 28
|
15 Best Stocks to Buy in 2024 According to Billionaire D.E. Shaw
|
|
Dec 27
|
Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing
|
|
Dec 27
|
Moderna and Pfizer Stock Tumbled in 2023. Wall Street Sees a Rebound.
|
|
Dec 26
|
13 High Growth Healthcare Stocks to Buy
|
|
Dec 23
|
Are Investors Overreacting to Pfizer's Underwhelming Forecast for 2024?
|
|
Dec 23
|
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
|
|
Dec 22
|
Pharma Stock Roundup: FDA Nod to AZN's Eplontersen, CRL to MRK's Cough Candidate
|